Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (111-120 of 937) with videos related to

Pageof 94
Sort By:
STAR Protocols|November 5, 2023
Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studiesThomas Look, Hanna Meister, Michael Weller, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
Neuro-Oncology|October 31, 2015
Immunosuppressive mechanisms in glioblastomaEdjah K Nduom, Michael Weller, Amy B Heimberger
Expert Review of Anticancer Therapy|October 25, 2013
Tumor-associated edema in brain cancer patients: pathogenesis and managementPatrick Roth, Luca Regli, Michaela Tonder, et al.
Current Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligandJohannes Rieger, Brigitte Frank, Michael Weller, et al.
Neuro-Oncology Advances|October 10, 2022
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivoEvelina Blomberg, Manuela Silginer, Patrick Roth, et al.
Nature Medicine|July 9, 2009
Will integrin inhibitors have proangiogenic effects in the clinic?Michael Weller, David Reardon, Burt Nabors, et al.
Nature Reviews. Clinical Oncology|April 13, 2018
Current state of immunotherapy for glioblastomaMichael Lim, Yuanxuan Xia, Chetan Bettegowda, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Pathogenesis and management of primary CNS lymphomaPatrick Roth, Agnieszka Korfel, Peter Martus, et al.
Pageof 94

Showing results (111-120 of 937) with videos related to

Sort By:
Pageof 94
STAR Protocols|November 5, 2023
Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studiesThomas Look, Hanna Meister, Michael Weller, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
Neuro-Oncology|October 31, 2015
Immunosuppressive mechanisms in glioblastomaEdjah K Nduom, Michael Weller, Amy B Heimberger
Expert Review of Anticancer Therapy|October 25, 2013
Tumor-associated edema in brain cancer patients: pathogenesis and managementPatrick Roth, Luca Regli, Michaela Tonder, et al.
Current Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligandJohannes Rieger, Brigitte Frank, Michael Weller, et al.
Neuro-Oncology Advances|October 10, 2022
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivoEvelina Blomberg, Manuela Silginer, Patrick Roth, et al.
Nature Medicine|July 9, 2009
Will integrin inhibitors have proangiogenic effects in the clinic?Michael Weller, David Reardon, Burt Nabors, et al.
Nature Reviews. Clinical Oncology|April 13, 2018
Current state of immunotherapy for glioblastomaMichael Lim, Yuanxuan Xia, Chetan Bettegowda, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Pathogenesis and management of primary CNS lymphomaPatrick Roth, Agnieszka Korfel, Peter Martus, et al.
Pageof 94